meRfi®-GM
Pembrolizumab & Primary mediastinal B-cell lymphoma (PMBCL)
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
Pembrolizumab showed tolerable safety profile and efficacy data in patients with Primary mediastinal B-cell lymphoma (PMBCL) who have relapsed after, or are ineligible for ASCT (autologous stem cell transplantation)
References:
see also:
Immune Checkpoint Inhibitors (ICIs) & Primary mediastinal B-cell lymphoma (PMBCL)
…